v3.25.4
Share-based Compensation (Tables)
 9 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
The following table summarizes the components of total share-based compensation expense included in the condensed consolidated statements of operations for each period presented (in thousands):
Three Months Ended December 31,Nine Months Ended December 31,
2025202420252024
Cost of revenue$10,792 $9,821 $30,657 $27,265 
Research and development29,160 26,582 85,739 74,769 
Sales and marketing21,883 20,709 64,493 57,481 
General and administrative16,083 15,027 45,738 41,984 
Total share-based compensation$77,918 $72,139 $226,627 $201,499 
Schedule of Restricted Stock Awards (RSA) and Restricted Stock Units (RSU)
The following table provides a summary of the changes in the number of restricted stock units (“RSUs”) and restricted stock awards (“RSAs”) for the nine months ended December 31, 2025:
Number of RSUs
Weighted Average
Grant Date Fair Value
Number of
 RSAs
Weighted Average
Grant Date Fair Value
(in thousands)(per share)(in thousands)(per share)
Balance, March 31, 202510,024 $48.33 95 $49.05 
Granted6,642 54.82 41 49.05 
Vested(4,692)47.82 (59)49.05 
Forfeited(776)50.84 — — 
Balance, December 31, 202511,198 $52.22 77 $49.05 
Schedule of Activity for Stock Options
The following table summarizes activity for stock options during the nine months ended December 31, 2025:
Number of Options
Weighted Average
Exercise Price
Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
(in thousands)(per share)(years)(in thousands)
Balance, March 31, 20252,072 $22.07 
Exercised(234)20.10 
Forfeited or expired(27)35.46 
Balance, December 31, 20251,811 $22.13 3.8$38,937 
Options vested and expected to vest at December 31, 20251,811 $22.13 3.8$38,937 
Options vested and exercisable at December 31, 20251,811 $22.13 3.8$38,937